
COVID-19 and Cancer Consortium (CCC19) Registry
@covid19nccc
COVID-19 & Cancer Consortium (#CCC19) Registry. ccc19.org, #COVID19nCancer, Vanderbilt IRB #200467
PI: @hemoncwarner
ID: 1241734168507285504
http://ccc19.org 22-03-2020 14:33:21
4,4K Tweet
2,2K Followers
110 Following

COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer [Dec 24, 2021] Andrew Schmidt et al. Toni Choueiri, MD COVID-19 and Cancer Consortium (CCC19) Registry Annals of Oncology ow.ly/tB9F50HiP4q #COVID19 #COVID19Vaccine #CCC19 #COVID19nCancer #IDonc
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer [Dec 24, 2021] <a href="/dr_aschmidt/">Andrew Schmidt</a> et al. <a href="/DrChoueiri/">Toni Choueiri, MD</a> <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/Annals_Oncology/">Annals of Oncology</a> ow.ly/tB9F50HiP4q #COVID19 #COVID19Vaccine #CCC19 #COVID19nCancer #IDonc COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer [Dec 24, 2021] <a href="/dr_aschmidt/">Andrew Schmidt</a> et al. <a href="/DrChoueiri/">Toni Choueiri, MD</a> <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/Annals_Oncology/">Annals of Oncology</a> ow.ly/tB9F50HiP4q #COVID19 #COVID19Vaccine #CCC19 #COVID19nCancer #IDonc](https://pbs.twimg.com/media/GskADBNXUAAjW6A.jpg)

Five Questions With: Sanjay Mishra Sanjay Mishra, PhD [Nov 26, 2023] By Katie Castellani PBN pbn.com/five-questionsโฆ #CCC19 COVID-19 and Cancer Consortium (CCC19) Registry #COVID19nCancer #COVID19Vaccine Donna Rivera @NCIJBSloan
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo Five Questions With: Sanjay Mishra <a href="/Ecquis/">Sanjay Mishra, PhD</a> [Nov 26, 2023] By <a href="/Katie_c912/">Katie Castellani</a> <a href="/ProvBusNews/">PBN</a>
pbn.com/five-questionsโฆ #CCC19 <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> #COVID19nCancer #COVID19Vaccine <a href="/DrDonnaRivera/">Donna Rivera</a> @NCIJBSloan Five Questions With: Sanjay Mishra <a href="/Ecquis/">Sanjay Mishra, PhD</a> [Nov 26, 2023] By <a href="/Katie_c912/">Katie Castellani</a> <a href="/ProvBusNews/">PBN</a>
pbn.com/five-questionsโฆ #CCC19 <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> #COVID19nCancer #COVID19Vaccine <a href="/DrDonnaRivera/">Donna Rivera</a> @NCIJBSloan](https://pbs.twimg.com/media/GskAGt_WsAAWK9O.png)

Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] Petros Grivas Ali Khaki et al. COVID-19 and Cancer Consortium (CCC19) Registry Annals of Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] <a href="/PGrivasMDPhD/">Petros Grivas</a> <a href="/arkhaki/">Ali Khaki</a> et al. <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/Annals_Oncology/">Annals of Oncology</a> ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] <a href="/PGrivasMDPhD/">Petros Grivas</a> <a href="/arkhaki/">Ali Khaki</a> et al. <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/Annals_Oncology/">Annals of Oncology</a> ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer](https://pbs.twimg.com/media/GskAXoUXkAAyaYU.png)

Assoc Clinical Factors & Recent Anti-Cancer Therapy w/ #COVID19 Severity among Pts w/ Cancer: A Report from the COVID-19 & Cancer Consortium [3/18/21] Petros Grivas Ali Khaki et al. COVID-19 and Cancer Consortium (CCC19) Registry Annals of Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer Highlights
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo Assoc Clinical Factors & Recent Anti-Cancer Therapy w/ #COVID19 Severity among Pts w/ Cancer: A Report from the COVID-19 & Cancer Consortium [3/18/21] <a href="/PGrivasMDPhD/">Petros Grivas</a> <a href="/arkhaki/">Ali Khaki</a> et al. <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/Annals_Oncology/">Annals of Oncology</a> ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer Highlights Assoc Clinical Factors & Recent Anti-Cancer Therapy w/ #COVID19 Severity among Pts w/ Cancer: A Report from the COVID-19 & Cancer Consortium [3/18/21] <a href="/PGrivasMDPhD/">Petros Grivas</a> <a href="/arkhaki/">Ali Khaki</a> et al. <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/Annals_Oncology/">Annals of Oncology</a> ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer Highlights](https://pbs.twimg.com/media/GskAabwWcAAJXMy.jpg)

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19 [Nov 3, 2022] Ziad Bakouny, MD, MSc et al. Toni Choueiri, MD Trisha Wise-Draper, MD, PhD COVID-19 and Cancer Consortium (CCC19) Registry JAMA Oncology jamanetwork.com/journals/jamaoโฆ #COVID19nCancer #CCC19 #IDonc #ImmunoOnc #NCT04354701
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19 [Nov 3, 2022] <a href="/ZiadBakouny/">Ziad Bakouny, MD, MSc</a> et al. <a href="/DrChoueiri/">Toni Choueiri, MD</a> <a href="/TMWiseDraper/">Trisha Wise-Draper, MD, PhD</a> <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/JAMAOnc/">JAMA Oncology</a> jamanetwork.com/journals/jamaoโฆ #COVID19nCancer #CCC19 #IDonc #ImmunoOnc #NCT04354701 Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19 [Nov 3, 2022] <a href="/ZiadBakouny/">Ziad Bakouny, MD, MSc</a> et al. <a href="/DrChoueiri/">Toni Choueiri, MD</a> <a href="/TMWiseDraper/">Trisha Wise-Draper, MD, PhD</a> <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/JAMAOnc/">JAMA Oncology</a> jamanetwork.com/journals/jamaoโฆ #COVID19nCancer #CCC19 #IDonc #ImmunoOnc #NCT04354701](https://pbs.twimg.com/media/GskAeslW0AAfoXm.png)

COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] Aakash Desai, MD, MPH, FASCO Turab J Mohammed, MD et al. JAMA Oncology ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 COVID-19 and Cancer Consortium (CCC19) Registry
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] <a href="/ADesaiMD/">Aakash Desai, MD, MPH, FASCO</a> <a href="/DrTJM_MD/">Turab J Mohammed, MD</a> et al. <a href="/JAMAOnc/">JAMA Oncology</a> ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] <a href="/ADesaiMD/">Aakash Desai, MD, MPH, FASCO</a> <a href="/DrTJM_MD/">Turab J Mohammed, MD</a> et al. <a href="/JAMAOnc/">JAMA Oncology</a> ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a>](https://pbs.twimg.com/media/GskAh8oXwAACRXr.png)

Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] Aakash Desai, MD, MPH, FASCO @hemoncwarner Dr K., MD, MS, FASCO ๐๐บ๐ธ๐ช๐บ๐บ๐ฆ๐ Mike Thompson, MD, PhD, FASCO Dear Dr. Researcher, PhD Gary Lyman ๐บ๐ธ๐ช๐บ๐บ๐ฆ๐๐ gilberto lopes Nature Cancer ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER COVID-19 and Cancer Consortium (CCC19) Registry

Coinfections in Patients with Cancer and COVID-19: A COVID-19 and Cancer Consortium (#CCC19) Study [Feb 14, 2022] Satyanarayana et al. Dimitrios Farmakiotis COVID-19 and Cancer Consortium (CCC19) Registry Open Forum Infectious Diseases ow.ly/uHAz50HUZav #COVID19nCancer #IDonc #COVID19
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo Coinfections in Patients with Cancer and COVID-19: A COVID-19 and Cancer Consortium (#CCC19) Study [Feb 14, 2022] Satyanarayana et al. <a href="/DFarmakiotis/">Dimitrios Farmakiotis</a> <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> Open Forum Infectious Diseases ow.ly/uHAz50HUZav #COVID19nCancer #IDonc #COVID19 Coinfections in Patients with Cancer and COVID-19: A COVID-19 and Cancer Consortium (#CCC19) Study [Feb 14, 2022] Satyanarayana et al. <a href="/DFarmakiotis/">Dimitrios Farmakiotis</a> <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> Open Forum Infectious Diseases ow.ly/uHAz50HUZav #COVID19nCancer #IDonc #COVID19](https://pbs.twimg.com/media/GskAomdWUAAT7UR.jpg)




Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] Sam Rubinstein et al. Mike Thompson, MD, PhD, FASCO COVID-19 and Cancer Consortium (CCC19) Registry Blood Cancer Discovery ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] <a href="/rubinstein_md/">Sam Rubinstein</a> et al. <a href="/mtmdphd/">Mike Thompson, MD, PhD, FASCO</a> <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/BCD_AACR/">Blood Cancer Discovery</a> ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] <a href="/rubinstein_md/">Sam Rubinstein</a> et al. <a href="/mtmdphd/">Mike Thompson, MD, PhD, FASCO</a> <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/BCD_AACR/">Blood Cancer Discovery</a> ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm](https://pbs.twimg.com/media/GtptDNXboAEn5W7.jpg)

COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] Aakash Desai, MD, MPH, FASCO Turab J Mohammed, MD et al. JAMA Oncology ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 COVID-19 and Cancer Consortium (CCC19) Registry
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] <a href="/ADesaiMD/">Aakash Desai, MD, MPH, FASCO</a> <a href="/DrTJM_MD/">Turab J Mohammed, MD</a> et al. <a href="/JAMAOnc/">JAMA Oncology</a> ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] <a href="/ADesaiMD/">Aakash Desai, MD, MPH, FASCO</a> <a href="/DrTJM_MD/">Turab J Mohammed, MD</a> et al. <a href="/JAMAOnc/">JAMA Oncology</a> ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a>](https://pbs.twimg.com/media/GtptP0qWQAADqoI.png)

Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] Aakash Desai, MD, MPH, FASCO @hemoncwarner Dr K., MD, MS, FASCO ๐๐บ๐ธ๐ช๐บ๐บ๐ฆ๐ Mike Thompson, MD, PhD, FASCO Dear Dr. Researcher, PhD Gary Lyman ๐บ๐ธ๐ช๐บ๐บ๐ฆ๐๐ gilberto lopes Nature Cancer ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER COVID-19 and Cancer Consortium (CCC19) Registry
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] <a href="/ADesaiMD/">Aakash Desai, MD, MPH, FASCO</a> @hemoncwarner <a href="/NicoleKuderer/">Dr K., MD, MS, FASCO ๐๐บ๐ธ๐ช๐บ๐บ๐ฆ๐</a> <a href="/mtmdphd/">Mike Thompson, MD, PhD, FASCO</a> <a href="/corrie_painter/">Dear Dr. Researcher, PhD</a> <a href="/gary_lyman/">Gary Lyman ๐บ๐ธ๐ช๐บ๐บ๐ฆ๐๐</a> <a href="/GlopesMd/">gilberto lopes</a> <a href="/NatureCancer/">Nature Cancer</a> ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] <a href="/ADesaiMD/">Aakash Desai, MD, MPH, FASCO</a> @hemoncwarner <a href="/NicoleKuderer/">Dr K., MD, MS, FASCO ๐๐บ๐ธ๐ช๐บ๐บ๐ฆ๐</a> <a href="/mtmdphd/">Mike Thompson, MD, PhD, FASCO</a> <a href="/corrie_painter/">Dear Dr. Researcher, PhD</a> <a href="/gary_lyman/">Gary Lyman ๐บ๐ธ๐ช๐บ๐บ๐ฆ๐๐</a> <a href="/GlopesMd/">gilberto lopes</a> <a href="/NatureCancer/">Nature Cancer</a> ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a>](https://pbs.twimg.com/media/GtptTwPWQAA2Trz.png)

From a Tweet to The Lancet in 10 Weeks: COVID-Cancer Consortium [June 17, 2020] Helen Leask Medscape Oncology ow.ly/RJTr30qS9pf #CCC19 #COVID19 #COVDI19nCancer COVID-19 and Cancer Consortium (CCC19) Registry

Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] Petros Grivas Ali Khaki et al. COVID-19 and Cancer Consortium (CCC19) Registry Annals of Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] <a href="/PGrivasMDPhD/">Petros Grivas</a> <a href="/arkhaki/">Ali Khaki</a> et al. <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/Annals_Oncology/">Annals of Oncology</a> ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] <a href="/PGrivasMDPhD/">Petros Grivas</a> <a href="/arkhaki/">Ali Khaki</a> et al. <a href="/COVID19nCCC/">COVID-19 and Cancer Consortium (CCC19) Registry</a> <a href="/Annals_Oncology/">Annals of Oncology</a> ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer](https://pbs.twimg.com/media/GtptfHBaUAADim3.jpg)